In This Section      
Print This Page

Current News Releases

Current News Releases

Released: August 16, 2017

Learning “modules” shown to reduce “missed dose” rates by nurses


Results of a yearlong study funded by the Patient-Centered Outcomes Research Institute (PCORI) with more than 900 nurses at The Johns Hopkins Hospital suggest that well-designed online education can decrease the rate of nonadministration of prescribed and necessary doses of blood thinners to prevent potentially lethal blood clots in hospitalized patients.

Released: August 16, 2017


In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers. The test, the scientists say, is novel in that it can distinguish between DNA shed from tumors and other altered DNA that can be mistaken for cancer biomarkers.

Released: August 14, 2017

Review is first publication from national consortium of academic medical centers working to eliminate unnecessary medical tests, treatments and procedures


Researchers at the Johns Hopkins University School of Medicine and the Mayo Clinic have compiled peer-reviewed evidence and crafted a guideline designed to help physicians and medical centers stop the use of a widely ordered blood test that adds no value in evaluating patients with suspected heart attack.

Released: August 14, 2017

Results suggest serotonin loss may be a key player in cognitive decline, not just a side-effect of Alzheimer’s disease


In a study looking at brain scans of people with mild loss of thought and memory ability, Johns Hopkins researchers report evidence of lower levels of the serotonin transporter — a natural brain chemical that regulates mood, sleep and appetite.

Released: August 8, 2017


Johns Hopkins Kimmel Cancer Center scientists report they have discovered a biochemical process that gives prostate cancer cells the almost unnatural ability to change their shape, squeeze into other organs and take root in other parts of the body. The scientists say their cell culture and mouse studies of the process, which involves a cancer-related protein called AIM1, suggest potential ways to intercept or reverse the ability of cancers to metastasize, or spread.

Released: August 8, 2017


Radiocarbon dating of a fossilized leg bone from a Jamaican monkey called Xenothrix mcgregori suggests it may be the one of the most recent primate species anywhere in the world to become extinct, and it may solve a long-standing mystery about the cause of its demise. The short answer: human settlement of its island home.

Released: August 8, 2017

Named the #1 hospital in Maryland and #3 in the nation on the 2017–18 Best Hospitals list, making it the nation’s top-ranked hospital combined for both adult and pediatric care


Out of nearly 4,700 hospitals reviewed, The Johns Hopkins Hospital ranked #1 in Maryland and #3 in the nation in U.S. News & World Report’s 2017–18 Best Hospitals list. Thirteen specialties at The Johns Hopkins Hospital are now among the top 10 in the nation. Ten specialties are in the top five.

Released: August 7, 2017


Our brains interpret the world around us, taking in the sights, sounds, textures and smells of the world. But how does our brain respond when we observe art?
Released: August 2, 2017

Most are improperly stored, as well


In a review of half a dozen published studies in which patients self-reported use of opioids prescribed to them after surgery, researchers at Johns Hopkins report that a substantial majority of patients used only some or none of the pills, and more than 90 percent failed to dispose of the leftovers in recommended ways.

Released: July 31, 2017


A new study led by Johns Hopkins researchers suggests that testing for the presence of orthostatic hypotension, a form of low blood pressure, be performed within one minute of standing after a person has been lying down. Current guidelines recommend taking the measurement three minutes after a person stands up.

Released: July 26, 2017


Richard Chaisson, M.D., primary investigator of these studies and director of the Center for Tuberculosis Research at the Johns Hopkins University School of Medicine will be available at IAS 2017 to comment on this research.

Released: July 25, 2017


Alan Scott, Ph.D., associate professor in the McKusick-Nathans Institute of Genetic Medicine and codirector of the Genetic Resources Core Facility at the Johns Hopkins University School of Medicine is available to comment on the recent DNA sequencing of the endangered Hawaiian monk seal, Neomonachus schauinslandi.
Released: July 24, 2017

Johns Hopkins researchers analyze Medicaid expansion’s effect on emergency department visits across Maryland


As the debate surrounding the Affordable Care Act (ACA) looms in the U.S. Congress, Johns Hopkins researchers are weighing in on one aspect of the law. In 2014, as part of the ACA, Maryland was one of the states that expanded eligibility for its Medicaid program. One of the proposed benefits of expanding Medicaid under the ACA was a reduction in emergency department patient visits. However, some research prior to the ACA implementation found new Medicaid enrollees increased their visits to the emergency department.

Released: July 20, 2017

Johns Hopkins researchers say findings may be a wake-up call for primary care providers


Johns Hopkins researchers who distributed a survey at a retreat and medical update for primary care physicians (PCPs) report that the vast majority of the 140 doctors who responded could not identify all 11 risk factors that experts say qualify patients for prediabetes screening. The survey, they say, is believed to be one of the first to formally test PCPs’ knowledge of current professional guidelines for such screening.
Released: July 17, 2017

A mathematical method to measure the effectiveness of treating Afib


In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the standard of care treatment for atrial fibrillation, the most common irregular heartbeat disorder.  This has the potential to let physicians and patients know immediately following treatment whether it was effective, or whether they’ll need to anticipate another procedure in the future. 
Released: July 17, 2017

Discovery suggests that strategies to regulate immune system cell reactivity to injury and cell loss might one day unlock and boost human tissue and cellular regeneration


Researchers at Johns Hopkins Medicine report evidence that zebrafishes’ natural ability to regenerate their eyes’ retinal tissue can be accelerated by controlling the fishes’ immune systems. Because evolution likely conserved this mechanism of regenerative potential in other animals, the new findings may one day advance efforts to combat degenerative eye disease damage in humans.

Released: July 12, 2017

The 16-week M-1 Ventures program to provide dedicated startup support that facilitates the development of innovative health care solutions


Johns Hopkins Technology Ventures, Plank Industries, the University of Maryland (through UM Ventures), Brown Advisory and the Abell Foundation announced today that they are providing support for M-1 Ventures, a new Baltimore-based startup accelerator focused on connected health and fitness technologies. The 16-week program will be housed in FastForward East, an innovation hub on the Johns Hopkins medical campus, and will challenge startups selected from a national applicant pool to validate their business models, engage with customers and build on traction they have already generated. Additional support for the program comes from the Maryland Department of Commerce and Village Capital.

Released: July 11, 2017


Johns Hopkins physicians report success in a small study of a modified skin biopsy that hastens the earlier diagnosis of an inherited and progressively fatal nerve disease and seems to offer a clearer view of the disorder’s severity and progression. With a quicker and less invasive way to visualize the hallmark protein clumps of the rare but lethal disease — familial transthyretin amyloidosis — the researchers say they hope to more rapidly advance clinical trials of treatments that may slow the disease and extend patients’ lives.

Released: July 11, 2017

Test tube and mouse studies show TAK228 enhances the tumor-killing effects of radiation and chemotherapy


Laboratory studies suggest that an experimental drug already in early clinical trials for a variety of adult cancers might enhance radiation and chemotherapy for two childhood brain cancers that currently are virtually always fatal.

Released: July 10, 2017

Study also shows that so-called purer form of MDMA called Molly rarely is


Johns Hopkins scientists report that data collected over five years by volunteers who tested pills free of charge at music festivals and raves across the United States suggest that at least some recreational users of illegal drugs may choose not to take them if tests show the pills are adulterated or fake.